Skip to content
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjhemonc logo
VJRegenMed
Logo
  • Home (current)
  • Specialties
    Hematology
    Oncology
    Musculoskeletal Disorder
    Rare Disease
    Metabolic Disorder
    Cardiovascular Disease
    Ophthalmology
    Neurology
    Infectious Disease
    View all Specialties
  • Technologies
    Cell Therapy
    MSC
    iPSC
    Gene Therapy
    Genome Editing
    Extracellular Vesicles
    CAR-T Therapy
    TCR Therapy
    Tissue-Engineering & Biomaterials
    View all Technologies
  • Topics
    Treatment
    Immuno-Oncology
    Trial Updates
    Perspectives
    Manufacturing
    COVID-19
    View all Topics
  • Conferences
    ASH 2022
    TCT 2022
    Meeting on the Med 2022
    ICLE 2022
    Advanced Therapies Week 2022
    TERMIS 2021
    ESGCT 2021
    Meeting on the Mesa 2021
    Advanced Therapies 2021
    View all Conferences
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Ophthalmology

The future of omentum-based autologous tissue engineering 1:01
The future of omentum-based autologous tissue engineering
Asaf Toker • 19 Apr 2022
Tissue engineered corneas as a replacement for transplantation 2:52
Tissue engineered corneas as a replacement for transplantation
Mark Daniell • 8 Nov 2021
Developmental barriers to tissue engineered corneas 1:41
Developmental barriers to tissue engineered corneas
Mark Daniell • 8 Nov 2021
Repairing corneal perforations with LiQD Cornea 2:53
Repairing corneal perforations with LiQD Cornea
May Griffith • 12 Nov 2021
jCell: allogeneic cell therapy for retinitis pigmentosa 1:57
jCell: allogeneic cell therapy for retinitis pigmentosa
Gil Carrasquinho • 2 Jul 2021
Advanced therapies for retinitis pigmentosa 2:27
Advanced therapies for retinitis pigmentosa
Gil Carrasquinho • 2 Jul 2021
The future of gene therapies for the eye 1:27
The future of gene therapies for the eye
Sue Washer • 22 Oct 2021
Manufacturing challenges in the advanced therapies sector 2:29
Manufacturing challenges in the advanced therapies sector
Sue Washer • 22 Oct 2021
Addressing corneal donation shortages with tissue engineering 1:29
Addressing corneal donation shortages with tissue engineering
May Griffith • 12 Nov 2021
The role of regenerative medicine in the ophthalmological space 1:40
The role of regenerative medicine in the ophthalmological space
May Griffith • 12 Nov 2021
Treating keratoconus with tissue engineered corneas 2:41
Treating keratoconus with tissue engineered corneas
Mark Daniell • 8 Nov 2021
Increasing supply of corneas in the developing world 1:09
Increasing supply of corneas in the developing world
Mark Daniell • 8 Nov 2021
AAV-based gene therapy for X-linked retinitis pigmentosa 2:03
AAV-based gene therapy for X-linked retinitis pigmentosa
Sue Washer • 22 Oct 2021
Optogenetics in advanced retinitis pigmentosa 1:52
Optogenetics in advanced retinitis pigmentosa
Sue Washer • 22 Oct 2021
Treating achromatopsia with AAV-based gene therapy 2:12
Treating achromatopsia with AAV-based gene therapy
Sue Washer • 22 Oct 2021
Cell therapies for cone-rod dystrophy 2:30
Cell therapies for cone-rod dystrophy
Marie Csete • 20 Oct 2021
  • 1
  • 2
  • Next
Journal Pages
  • Specialties
  • Technologies
  • Topics
  • Conferences
Newsletter

Receive the latest news and videos from VJRegenMed via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJRegenMed logo
The content of VJRegenMed is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy